1
|
Sorge RE, Trang T, Dorfman R, Smith SB,
Beggs S, Ritchie J, Austin JS, Zaykin DV, Vander Meulen H, Costigan
M, et al: Genetically determined P2X7 receptor pore formation
regulates variability in chronic pain sensitivity. Nat Med.
18:595–599. 2012. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Neville A, Peleg R, Singer Y, Sherf M and
Shvartzman P: Chronic pain: A population-based study. Isr Med Assoc
J. 10:676–680. 2008.PubMed/NCBI
|
3
|
Baron R: Peripheral neuropathic pain: From
mechanisms to symptoms. Clin J Pain. 16(Suppl): S12–S20. 2000.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Dimitroulas T, Duarte RV, Behura A, Kitas
GD and Raphael JH: Neuropathic pain in osteoarthritis: A review of
pathophysiological mechanisms and implications for treatment. Semin
Arthritis Rheum. 44:145–154. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Phillips JR, Hopwood B, Arthur C, Stroud R
and Toms AD: The natural history of pain and neuropathic pain after
knee replacement: A prospective cohort study of the point
prevalence of pain and neuropathic pain to a minimum three-year
follow-up. Bone Joint J. 96-B:1227–1233. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Haanpää M, Attal N, Backonja M, Baron R,
Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA,
Iannetti GD, et al: NeuPSIG guidelines on neuropathic pain
assessment. Pain. 152:14–27. 2011. View Article : Google Scholar
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Ranganathan K and Sivasankar V: MicroRNAs
- Biology and clinical applications. J Oral Maxillofac Pathol.
18:229–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Sakai A and Suzuki H: Emerging roles of
microRNAs in chronic pain. Neurochem Int. 77:58–67. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
von Schack D, Agostino MJ, Murray BS, Li
Y, Reddy PS, Chen J, Choe SE, Strassle BW, Li C, Bates B, et al:
Dynamic changes in the microRNA expression profile reveal multiple
regulatory mechanisms in the spinal nerve ligation model of
neuropathic pain. PLoS One. 6:e176702011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Aldrich BT, Frakes EP, Kasuya J, Hammond
DL and Kitamoto T: Changes in expression of sensory organ-specific
microRNAs in rat dorsal root ganglia in association with mechanical
hypersensitivity induced by spinal nerve ligation. Neuroscience.
164:711–723. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Favereaux A, Thoumine O, Bouali-Benazzouz
R, Roques V, Papon MA, Salam SA, Drutel G, Léger C, Calas A, Nagy
F, et al: Bidirectional integrative regulation of Cav1.2 calcium
channel by microRNA miR-103: Role in pain. EMBO J. 30:3830–3841.
2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tan Y, Yang J, Xiang K, Tan Q and Guo Q:
Suppression of microRNA-155 attenuates neuropathic pain by
regulating SOCS1 signalling pathway. Neurochem Res. 40:550–560.
2015. View Article : Google Scholar
|
16
|
Andersson U, Erlandsson-Harris H, Yang H
and Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol.
72:1084–1091. 2002.PubMed/NCBI
|
17
|
Taniguchi N, Kawahara K, Yone K,
Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K,
Matsunaga S, et al: High mobility group box chromosomal protein 1
plays a role in the pathogenesis of rheumatoid arthritis as a novel
cytokine. Arthritis Rheum. 48:971–981. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Andersson U and Tracey KJ: HMGB1 in
sepsis. Scand J Infect Dis. 35:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
Oppenheim JJ and Yang D: Alarmins:
Chemotactic activators of immune responses. Curr Opin Immunol.
17:359–365. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Genevay S, Finckh A, Payer M, Mezin F,
Tessitore E, Gabay C and Guerne PA: Elevated levels of tumor
necrosis factor-alpha in periradicular fat tissue in patients with
radiculopathy from herniated disc. Spine. 33:2041–2046. 2008.
View Article : Google Scholar : PubMed/NCBI
|
21
|
McCarron RF, Wimpee MW, Hudkins PG and
Laros GS: The inflammatory effect of nucleus pulposus. A possible
element in the pathogenesis of low-back pain. Spine. 12:760–764.
1987. View Article : Google Scholar : PubMed/NCBI
|
22
|
Vallejo R, Tilley DM, Vogel L and Benyamin
R: The role of glia and the immune system in the development and
maintenance of neuropathic pain. Pain Pract. 10:167–184. 2010.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Chacur M, Milligan ED, Gazda LS, Armstrong
C, Wang H, Tracey KJ, Maier SF and Watkins LR: A new model of
sciatic inflammatory neuritis (SIN): Induction of unilateral and
bilateral mechanical allodynia following acute unilateral
peri-sciatic immune activation in rats. Pain. 94:231–244. 2001.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Shibasaki M, Sasaki M, Miura M, Mizukoshi
K, Ueno H, Hashimoto S, Tanaka Y and Amaya F: Induction of high
mobility group box-1 in dorsal root ganglion contributes to pain
hypersensitivity after peripheral nerve injury. Pain. 149:514–521.
2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Feldman P, Due MR, Ripsch MS, Khanna R and
White FA: The persistent release of HMGB1 contributes to tactile
hyperalgesia in a rodent model of neuropathic pain. J
Neuroinflammation. 9(180)2012. View Article : Google Scholar
|
26
|
Otoshi K, Kikuchi S, Kato K, Sekiguchi M
and Konno S: Anti-HMGB1 neutralization antibody improves
pain-related behavior induced by application of autologous nucleus
pulposus onto nerve roots in rats. Spine. 36:E692–E698. 2011.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Chen HP, Zhou W, Kang LM, Yan H, Zhang L,
Xu BH and Cai WH: Intrathecal miR-96 inhibits Nav1.3 expression and
alleviates neuropathic pain in rat following chronic construction
injury. Neurochem Res. 39:76–83. 2014. View Article : Google Scholar
|
28
|
Bennett GJ and Xie YK: A peripheral
mononeuropathy in rat that produces disorders of pain sensation
like those seen in man. Pain. 33:87–107. 1988. View Article : Google Scholar : PubMed/NCBI
|
29
|
Yaksh TL and Rudy TA: Chronic
catheterization of the spinal subarachnoid space. Physiol Behav.
17:1031–1036. 1976. View Article : Google Scholar : PubMed/NCBI
|
30
|
Chaplan SR, Bach FW, Pogrel JW, Chung JM
and Yaksh TL: Quantitative assessment of tactile allodynia in the
rat paw. J Neurosci Methods. 53:55–63. 1994. View Article : Google Scholar : PubMed/NCBI
|
31
|
Hargreaves K, Dubner R, Brown F, Flores C
and Joris J: A new and sensitive method for measuring thermal
nociception in cutaneous hyperalgesia. Pain. 32:77–88. 1988.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Zhang H, Cang CL, Kawasaki Y, Liang LL,
Zhang YQ, Ji RR and Zhao ZQ: Neurokinin-1 receptor enhances TRPV1
activity in primary sensory neurons via PKCepsilon: A novel pathway
for heat hyperalgesia. J Neurosci. 27:12067–12077. 2007. View Article : Google Scholar : PubMed/NCBI
|
33
|
Maeda T, Ozaki M, Kobayashi Y, Kiguchi N
and Kishioka S: HMGB1 as a potential therapeutic target for
neuropathic pain. J Pharmacol Sci. 123:301–305. 2013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Gong Q, Lu Z, Huang Q, Ruan L, Chen J,
Liang Y, Wang H, Yue Y and Feng S: Altered microRNAs expression
profiling in mice with diabetic neuropathic pain. Biochem Biophys
Res Commun. 456:615–620. 2015. View Article : Google Scholar
|
35
|
Norcini M, Sideris A, Martin Hernandez LA,
Zhang J, Blanck TJ and Recio-Pinto E: An approach to identify
microRNAs involved in neuropathic pain following a peripheral nerve
injury. Front Neurosci. 8(266)2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Im YB, Jee MK, Jung JS, Choi JI, Jang JH
and Kang SK: miR23b ameliorates neuropathic pain in spinal cord by
silencing NADPH oxidase 4. Antioxid Redox Signal. 16:1046–1060.
2012. View Article : Google Scholar
|
37
|
Im YB, Jee MK, Choi JI, Cho HT, Kwon OH
and Kang SK: Molecular targeting of NOX4 for neuropathic pain after
traumatic injury of the spinal cord. Cell Death Dis. 3:e4262012.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Willemen HL, Huo XJ, Mao-Ying QL, Zijlstra
J, Heijnen CJ and Kavelaars A: MicroRNA-124 as a novel treatment
for persistent hyperalgesia. J Neuroinflammation. 9(143)2012.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Shi G, Shi J, Liu K, Liu N, Wang Y, Fu Z,
Ding J, Jia L and Yuan W: Increased miR-195 aggravates neuropathic
pain by inhibiting autophagy following peripheral nerve injury.
Glia. 61:504–512. 2013. View Article : Google Scholar : PubMed/NCBI
|
40
|
Zhou X, Xia Y, Su J and Zhang G:
Down-regulation of miR-141 induced by helicobacter pylori promotes
the invasion of gastric cancer by targeting STAT4. Cell Physiol
Biochem. 33:1003–1012. 2014. View Article : Google Scholar : PubMed/NCBI
|
41
|
Zuo QF, Zhang R, Li BS, Zhao YL, Zhuang Y,
Yu T, Gong L, Li S, Xiao B and Zou QM: MicroRNA-141 inhibits tumor
growth and metastasis in gastric cancer by directly targeting
transcriptional co-activator with PDZ-binding motif, TAZ. Cell
Death Dis. 6:e16232015. View Article : Google Scholar : PubMed/NCBI
|
42
|
Sipert CR, Morandini AC, Dionísio TJ,
Machado MA, Oliveira SH, Campanelli AP, Kuo WP and Santos CF: In
vitro regulation of CCL3 and CXCL12 by bacterial by-products is
dependent on site of origin of human oral fibroblasts. J Endod.
40:95–100. 2014. View Article : Google Scholar
|
43
|
Huang Z, Shi T, Zhou Q, Shi S, Zhao R, Shi
H, Dong L, Zhang C, Zeng K, Chen J, et al: miR-141 Regulates
colonic leukocytic trafficking by targeting CXCL12β during murine
colitis and human Crohn's disease. Gut. 63:1247–1257. 2014.
View Article : Google Scholar
|
44
|
Lam WY, Yeung AC, Ngai KL, Li MS, To KF,
Tsui SK and Chan PK: Effect of avian influenza A H5N1 infection on
the expression of microRNA-141 in human respiratory epithelial
cells. BMC Microbiol. 13(104)2013. View Article : Google Scholar : PubMed/NCBI
|
45
|
Ren PC, Zhang Y, Zhang XD, An LJ, Lv HG,
He J, Gao CJ and Sun XD: High-mobility group box 1 contributes to
mechanical allodynia and spinal astrocytic activation in a mouse
model of type 2 diabetes. Brain Res Bull. 88:332–337. 2012.
View Article : Google Scholar : PubMed/NCBI
|
46
|
Nakamura Y, Morioka N, Abe H, Zhang FF,
Hisaoka-Nakashima K, Liu K, Nishibori M and Nakata Y: Neuropathic
pain in rats with a partial sciatic nerve ligation is alleviated by
intravenous injection of monoclonal antibody to high mobility group
box-1. PLoS One. 8:e736402013. View Article : Google Scholar : PubMed/NCBI
|
47
|
Tong W, Wang W, Huang J, Ren N, Wu SX and
Li YQ: Spinal high-mobility group box 1 contributes to mechanical
allodynia in a rat model of bone cancer pain. Biochem Biophys Res
Commun. 395:572–576. 2010. View Article : Google Scholar : PubMed/NCBI
|
48
|
Ma YQ, Chen YR, Leng YF and Wu ZW:
Tanshinone IIA downregulates HMGB1 and TLR4 expression in a spinal
nerve ligation model of neuropathic pain. Evid Based Complement
Alternat Med. 2014(639563)2014.
|
49
|
He Z, Guo Q, Xiao M, He C and Zou W:
Intrathecal lentivirus-mediated transfer of interleukin-10
attenuates chronic constriction injury-induced neuropathic pain
through modulation of spinal high-mobility group box 1 in rats.
Pain Physician. 16:E615–E625. 2013.PubMed/NCBI
|
50
|
Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang
Y, Wang Y, Zhao W and Wang W: miR-22 inhibits osteosarcoma cell
proliferation and migration by targeting HMGB1 and inhibiting
HMGB1-mediated autophagy. Tumour Biol. 35:7025–7034. 2014.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Lu F, Zhang J, Ji M, Li P, Du Y, Wang H,
Zang S, Ma D, Sun X and Ji C: miR-181b increases drug sensitivity
in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Int J
Oncol. 45:383–392. 2014.PubMed/NCBI
|